Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Submitted by
admin
on July 30, 2013 - 11:47am
Source:
Yahoo
News Tags:
GSK
Isis Pharmaceuticals
ISIS-TTRRx
antisense
Headline:
Isis Pharmaceuticals Earns $2 Million from GSK for the Advancement of ISIS-TTR Rx
Do Not Allow Advertisers to Use My Personal information
